Business Update

NIH gets help cataloging biological properties of small molecules

Published in Medical Letter on the CDC and FDA, January 22nd, 2006

Elsevier MDL today announced an agreement with the U.S. National Institutes of Health (NIH) to contribute to the NIH effort to catalog information on the biological properties of small molecules in its freely available PubChem database.

Elsevier MDL will enrich the growing PubChem resource for the scientific community by furnishing chemical structures from Elsevier's xPharm database, giving scientists with an xPharm license the ability to move from biological data in PubChem to more focused pharmacology data in xPharm that is essential to drug research.

"Elsevier MDL is pleased to collaborate with the NIH to give commercial, academic, and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2006-01-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry